Search

EU Elections and Health Policy

HemAffairs Article #1 – June 2019

2019 will see significant changes within the European institutions.

Read more

EPICOVIDEHA survey

COVID-19 infections in patients with Hematological Malignancies - Results from EHA-IDWP registry
EPICOVIDEHA is an international open web-based registry for patients with haematological malignancies infected with SARS-CoV-2,
The survey has been approved by the Institutional Review Board and Ethics Committee of the…

Read more

Connecting experts on inherited anemias and iron defects in Budapest

October 12-14, 2023 – Budapest, Hungary 

Meeting Chairs: 
Ali Taher, American University of Beirut Medical Center, Beirut, Lebanon 

Achille Iolascon, University Federico II of Naples, Naples, Italy 

In October 2023 EHA and the Specialized Working Group (SWG) on Red Cell and Iron hosted a…

Read more

In memoriam Daniel Catovsky

Professor Daniel Catovsky MD DSc
19. 9. 1937 – 2. 12. 2022

Daniel Catovsky died peacefully in December at the age of 85 years.

Read more

Highlights of Past EHA (HOPE) Latin America (LA) 2022 - report

November 17-19, 2022 – Barranquilla, Colombia

Meeting chairs:
D McLornan, Vice-Chair Global Outreach Program Committee, European Hematology Association (EHA)
V Abello Polo, President, Asociación Colombiana de Hematología y Oncología (ACHO)

This year, the HOPE LA meeting was held in collaboration with the Asociación Colombiana…

Read more

Myeloproliferative neoplasms better understood through scientific meeting

The EHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms held on October 12-14, 2017 in Budapest, Hungary received a 100% recommendation rating from attendees.

Read more

Report on first EHA-SWG Scientific Meeting

The meeting was organized with the main support of the EHA in collaboration with the Hematology Unit of G. Gaslini Children’s Hospital and was sponsored by Novartis and Alexion.

Read more

EHA Friends' Fund

Together, we can change the lives of many and make greater strides in the treatment of patients with blood disorders.

Read more